Table 1.

The clinical features of patients with PCa and their LRPPRC Levels.

Clinical Features	Case Numbers	LRPPRC Levels Mean ± Stdev	P Value
Tissue Type
PCa	112	4.6±1.4	<0.001
BPH	38	1.7±1.6
Age (years)
< 70	50	4.5±1.4	0.481
≥70	62	4.7±1.5
Gleason Score
< 8	91	4.4±1.3	0.090
≥8	21	5.3±1.7
Preoperative PSA
<10 ng/ml	41	4.2±1.1	0.018
≥10 ng/ml	71	4.8±1.5
Tumor Grade
I/II	61	4.1±1.4	<0.001
III	51	5.3±1.2
Metastasis
No	58	3.9±1.2	<0.001
Yes	54	5.3±1.3
HTSin2*
No	10	5.3±1.5	0.110
Yes	102	4.5±1.4
HTSaf2*
No	50	5.3±1.2	<0.001
Yes	62	3.9±1.2
Survival Time
<5 years	51	5.3±1.2	<0.001
≥5 years	61	3.9±1.3
Survival Time
<10 years	83	5.1±1.2	<0.001
≥10 years	29	3.2±1.1

^*HTSin2: Hormone Therapy Sensitivity within 2 Years.

^*HTSaf2: Hormone Therapy Sensitivity after 2 Years.